Status:
COMPLETED
Methods Study to Characterize Early Indicators of Weight Loss in People
Lead Sponsor:
Pfizer
Collaborating Sponsors:
University of Adelaide
Royal Adelaide Hospital
Conditions:
Obesity
Eligibility:
MALE
18-55 years
Phase:
NA
Brief Summary
Methods study to characterize early indicators of weight loss in people.
Eligibility Criteria
Inclusion
- Subjects \>=18 years of age with BMI \>= 30 and \< 40 kg/m2
Exclusion
- Females, those with illnesses expected to cause weight loss, those without stable body weight within 3 months of screening.
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT00383253
Start Date
October 1 2006
End Date
March 1 2008
Last Update
March 23 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Adelaide, South Australia, Australia, 5000
2
Pfizer Investigational Site
North Adelaide, South Australia, Australia, 5006